ID   STK16_HUMAN             Reviewed;         305 AA.
AC   O75716; A8K9H9; Q5U0F8; Q96KI2; Q9BUH4; Q9UEN3; Q9UP78;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   12-OCT-2022, entry version 203.
DE   RecName: Full=Serine/threonine-protein kinase 16;
DE            EC=2.7.11.1;
DE   AltName: Full=Myristoylated and palmitoylated serine/threonine-protein kinase;
DE            Short=MPSK;
DE   AltName: Full=Protein kinase PKL12;
DE   AltName: Full=TGF-beta-stimulated factor 1;
DE            Short=TSF-1;
DE   AltName: Full=Tyrosine-protein kinase STK16;
DE            EC=2.7.10.2;
DE   AltName: Full=hPSK;
GN   Name=STK16; Synonyms=MPSK1, PKL12, TSF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9712705; DOI=10.1006/bbrc.1998.9163;
RA   Ligos J.M., Gerwin N., Fernandez P., Gutierrez-Ramos J.-C., Bernad A.;
RT   "Cloning, expression analysis, and functional characterization of PKL12, a
RT   member of a new subfamily of ser/thr kinases.";
RL   Biochem. Biophys. Res. Commun. 249:380-384(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, FUNCTION,
RP   AUTOPHOSPHORYLATION, MYRISTOYLATION AT GLY-2, PALMITOYLATION AT CYS-6 AND
RP   CYS-8, AND MUTAGENESIS OF GLY-2; CYS-6 AND CYS-8.
RC   TISSUE=Dendritic cell;
RX   PubMed=10364453; DOI=10.1006/bbrc.1999.0811;
RA   Berson A.E., Young C., Morrison S.L., Fujii G.H., Sheung J., Wu B.,
RA   Bolen J.B., Burkhardt A.L.;
RT   "Identification and characterization of a myristylated and palmitylated
RT   serine/threonine protein kinase.";
RL   Biochem. Biophys. Res. Commun. 259:533-538(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10947953; DOI=10.1042/bj3500395;
RA   Ohta S., Takeuchi M., Deguchi M., Tsuji T., Gahara Y., Nagata K.;
RT   "A novel transcriptional factor with Ser/Thr kinase activity involved in
RT   the transforming growth factor (TGF)-beta signalling pathway.";
RL   Biochem. J. 350:395-404(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RA   Wabakken T.K., Aasheim H.-C.;
RT   "Characterization of a ubiquitous expressed human serine/threonine
RT   kinase.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Stairs D.B., Ha S.I., Chodosh L.A.;
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TRP-266.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TRP-266.
RC   TISSUE=Colon, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 13-304 OF WILD TYPE AND IN COMPLEX
RP   WITH STAUROSPORINE, SUBUNIT, INTERACTION WITH DRG1, PHOSPHORYLATION AT
RP   THR-185; SER-197 AND TYR-198, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18184589; DOI=10.1016/j.str.2007.10.026;
RA   Eswaran J., Bernad A., Ligos J.M., Guinea B., Debreczeni J.E., Sobott F.,
RA   Parker S.A., Najmanovich R., Turk B.E., Knapp S.;
RT   "Structure of the human protein kinase MPSK1 reveals an atypical activation
RT   loop architecture.";
RL   Structure 16:115-124(2008).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-41; LYS-55; VAL-77; TRP-266 AND
RP   LEU-277.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Membrane-associated protein kinase that phosphorylates on
CC       serine and threonine residues. In vitro substrates include DRG1, ENO1
CC       and EIF4EBP1. Also autophosphorylates. May be involved in secretory
CC       vesicle trafficking or intracellular signaling. May have a role in
CC       regulating stromal-epithelial interactions that occur during ductal
CC       morphogenesis in the mammary gland. May be involved in TGF-beta
CC       signaling. Able to autophosphorylate on Tyr residue; it is however
CC       unclear whether it has tyrosine-protein kinase toward other proteins.
CC       {ECO:0000269|PubMed:10364453}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};
CC   -!- SUBUNIT: Monomer. Interacts with DRG1 (via its N-terminal); the
CC       interaction phosphorylates DRG1. {ECO:0000269|PubMed:18184589}.
CC   -!- INTERACTION:
CC       O75716; Q6UY14: ADAMTSL4; NbExp=3; IntAct=EBI-749295, EBI-742002;
CC       O75716; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-749295, EBI-10173507;
CC       O75716; O95994: AGR2; NbExp=3; IntAct=EBI-749295, EBI-712648;
CC       O75716; Q9HBZ2: ARNT2; NbExp=3; IntAct=EBI-749295, EBI-765971;
CC       O75716; Q9Y6H3: ATP23; NbExp=3; IntAct=EBI-749295, EBI-12811889;
CC       O75716; Q7RTU4: BHLHA9; NbExp=3; IntAct=EBI-749295, EBI-17508719;
CC       O75716; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-749295, EBI-739580;
CC       O75716; Q13185: CBX3; NbExp=3; IntAct=EBI-749295, EBI-78176;
CC       O75716; P27918: CFP; NbExp=3; IntAct=EBI-749295, EBI-9038570;
CC       O75716; O43186: CRX; NbExp=3; IntAct=EBI-749295, EBI-748171;
CC       O75716; A8MUP2: CSKMT; NbExp=3; IntAct=EBI-749295, EBI-12842046;
CC       O75716; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-749295, EBI-3867333;
CC       O75716; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-749295, EBI-742054;
CC       O75716; Q96EY1-2: DNAJA3; NbExp=3; IntAct=EBI-749295, EBI-3952284;
CC       O75716; Q9Y295: DRG1; NbExp=3; IntAct=EBI-749295, EBI-719554;
CC       O75716; O95967: EFEMP2; NbExp=6; IntAct=EBI-749295, EBI-743414;
CC       O75716; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-749295, EBI-2349927;
CC       O75716; Q96Q35: FLACC1; NbExp=3; IntAct=EBI-749295, EBI-750451;
CC       O75716; O43559: FRS3; NbExp=3; IntAct=EBI-749295, EBI-725515;
CC       O75716; P51114-2: FXR1; NbExp=3; IntAct=EBI-749295, EBI-11022345;
CC       O75716; Q06546: GABPA; NbExp=3; IntAct=EBI-749295, EBI-638925;
CC       O75716; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-749295, EBI-747204;
CC       O75716; Q0VD86: INCA1; NbExp=6; IntAct=EBI-749295, EBI-6509505;
CC       O75716; Q9BQ13: KCTD14; NbExp=4; IntAct=EBI-749295, EBI-10189448;
CC       O75716; Q9BQ13-2: KCTD14; NbExp=3; IntAct=EBI-749295, EBI-12278688;
CC       O75716; Q8N5Z5: KCTD17; NbExp=9; IntAct=EBI-749295, EBI-743960;
CC       O75716; Q8N5Z5-2: KCTD17; NbExp=3; IntAct=EBI-749295, EBI-10189368;
CC       O75716; Q9BS75: KLHL20; NbExp=3; IntAct=EBI-749295, EBI-10693436;
CC       O75716; Q5T749: KPRP; NbExp=3; IntAct=EBI-749295, EBI-10981970;
CC       O75716; Q15323: KRT31; NbExp=3; IntAct=EBI-749295, EBI-948001;
CC       O75716; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-749295, EBI-11959885;
CC       O75716; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-749295, EBI-11749135;
CC       O75716; P60370: KRTAP10-5; NbExp=3; IntAct=EBI-749295, EBI-10172150;
CC       O75716; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-749295, EBI-10172290;
CC       O75716; P60410: KRTAP10-8; NbExp=6; IntAct=EBI-749295, EBI-10171774;
CC       O75716; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-749295, EBI-10172052;
CC       O75716; Q8IUC1: KRTAP11-1; NbExp=3; IntAct=EBI-749295, EBI-1052037;
CC       O75716; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-749295, EBI-11953846;
CC       O75716; Q6PEX3: KRTAP26-1; NbExp=3; IntAct=EBI-749295, EBI-3957672;
CC       O75716; P50222: MEOX2; NbExp=3; IntAct=EBI-749295, EBI-748397;
CC       O75716; Q7Z3K6-2: MIER3; NbExp=3; IntAct=EBI-749295, EBI-12224671;
CC       O75716; Q5JXC2: MIIP; NbExp=4; IntAct=EBI-749295, EBI-2801965;
CC       O75716; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-749295, EBI-742948;
CC       O75716; Q93015-2: NAA80; NbExp=5; IntAct=EBI-749295, EBI-12126220;
CC       O75716; Q9GZT8: NIF3L1; NbExp=3; IntAct=EBI-749295, EBI-740897;
CC       O75716; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-749295, EBI-945833;
CC       O75716; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-749295, EBI-22310682;
CC       O75716; Q92824: PCSK5; NbExp=3; IntAct=EBI-749295, EBI-751290;
CC       O75716; Q96KN3: PKNOX2; NbExp=3; IntAct=EBI-749295, EBI-2692890;
CC       O75716; O15496: PLA2G10; NbExp=3; IntAct=EBI-749295, EBI-726466;
CC       O75716; O15162: PLSCR1; NbExp=3; IntAct=EBI-749295, EBI-740019;
CC       O75716; Q9NRY6: PLSCR3; NbExp=6; IntAct=EBI-749295, EBI-750734;
CC       O75716; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-749295, EBI-11320284;
CC       O75716; P31321: PRKAR1B; NbExp=3; IntAct=EBI-749295, EBI-2805516;
CC       O75716; Q03431: PTH1R; NbExp=3; IntAct=EBI-749295, EBI-2860297;
CC       O75716; Q04864: REL; NbExp=3; IntAct=EBI-749295, EBI-307352;
CC       O75716; Q04864-2: REL; NbExp=3; IntAct=EBI-749295, EBI-10829018;
CC       O75716; Q8HWS3: RFX6; NbExp=3; IntAct=EBI-749295, EBI-746118;
CC       O75716; P49247: RPIA; NbExp=4; IntAct=EBI-749295, EBI-744831;
CC       O75716; Q2I0M5: RSPO4; NbExp=3; IntAct=EBI-749295, EBI-12821217;
CC       O75716; Q8IYX7: SAXO1; NbExp=6; IntAct=EBI-749295, EBI-3957636;
CC       O75716; P12757: SKIL; NbExp=3; IntAct=EBI-749295, EBI-2902468;
CC       O75716; O14508: SOCS2; NbExp=3; IntAct=EBI-749295, EBI-617737;
CC       O75716; O43597: SPRY2; NbExp=3; IntAct=EBI-749295, EBI-742487;
CC       O75716; Q99081: TCF12; NbExp=3; IntAct=EBI-749295, EBI-722877;
CC       O75716; P15884: TCF4; NbExp=3; IntAct=EBI-749295, EBI-533224;
CC       O75716; Q08117: TLE5; NbExp=3; IntAct=EBI-749295, EBI-717810;
CC       O75716; Q13829: TNFAIP1; NbExp=3; IntAct=EBI-749295, EBI-2505861;
CC       O75716; O43734: TRAF3IP2; NbExp=3; IntAct=EBI-749295, EBI-744798;
CC       O75716; P14373: TRIM27; NbExp=3; IntAct=EBI-749295, EBI-719493;
CC       O75716; Q8IWZ5: TRIM42; NbExp=6; IntAct=EBI-749295, EBI-5235829;
CC       O75716; Q15654: TRIP6; NbExp=3; IntAct=EBI-749295, EBI-742327;
CC       O75716; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-749295, EBI-11975223;
CC       O75716; Q9Y3S2: ZNF330; NbExp=6; IntAct=EBI-749295, EBI-373456;
CC       O75716; Q6P1L6: ZNF343; NbExp=3; IntAct=EBI-749295, EBI-10252492;
CC       O75716; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-749295, EBI-10251462;
CC       O75716; P32233: Drg1; Xeno; NbExp=4; IntAct=EBI-749295, EBI-8429215;
CC       O75716; Q7DB77: tir; Xeno; NbExp=3; IntAct=EBI-749295, EBI-6480811;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Membrane
CC       {ECO:0000250}; Lipid-anchor {ECO:0000250}. Note=Associates with Golgi
CC       and Golgi-derived vesicles. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed at very low levels.
CC       {ECO:0000269|PubMed:10364453}.
CC   -!- PTM: Mainly autophosphorylated on serine/threonine residues. Also
CC       autophosphorylated on Tyr-198. {ECO:0000269|PubMed:18184589}.
CC   -!- PTM: It is uncertain whether palmitoylation is on Cys-6 and/or Cys-8.
CC       {ECO:0000269|PubMed:10364453}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAV38392.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA06700.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ005791; CAA06700.1; ALT_FRAME; mRNA.
DR   EMBL; AF060798; AAC28337.1; -; mRNA.
DR   EMBL; AB020739; BAB16311.1; -; mRNA.
DR   EMBL; AJ010872; CAA09387.1; -; mRNA.
DR   EMBL; AF203910; AAG23728.1; -; mRNA.
DR   EMBL; BT019585; AAV38392.1; ALT_FRAME; mRNA.
DR   EMBL; AK292694; BAF85383.1; -; mRNA.
DR   EMBL; CR407675; CAG28603.1; -; mRNA.
DR   EMBL; BC002618; AAH02618.1; -; mRNA.
DR   EMBL; BC053998; AAH53998.1; -; mRNA.
DR   CCDS; CCDS42822.1; -.
DR   RefSeq; NP_001008910.1; NM_001008910.3.
DR   RefSeq; NP_001317142.1; NM_001330213.1.
DR   PDB; 2BUJ; X-ray; 2.60 A; A/B=13-305.
DR   PDBsum; 2BUJ; -.
DR   AlphaFoldDB; O75716; -.
DR   SMR; O75716; -.
DR   BioGRID; 114144; 158.
DR   DIP; DIP-29598N; -.
DR   IntAct; O75716; 99.
DR   MINT; O75716; -.
DR   STRING; 9606.ENSP00000386928; -.
DR   BindingDB; O75716; -.
DR   ChEMBL; CHEMBL3938; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; O75716; -.
DR   GuidetoPHARMACOLOGY; 2213; -.
DR   GlyGen; O75716; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75716; -.
DR   PhosphoSitePlus; O75716; -.
DR   SwissPalm; O75716; -.
DR   BioMuta; STK16; -.
DR   EPD; O75716; -.
DR   jPOST; O75716; -.
DR   MassIVE; O75716; -.
DR   PaxDb; O75716; -.
DR   PeptideAtlas; O75716; -.
DR   PRIDE; O75716; -.
DR   ProteomicsDB; 50174; -.
DR   Antibodypedia; 34316; 285 antibodies from 25 providers.
DR   DNASU; 8576; -.
DR   Ensembl; ENST00000396738.7; ENSP00000379964.2; ENSG00000115661.14.
DR   Ensembl; ENST00000409638.7; ENSP00000386928.3; ENSG00000115661.14.
DR   GeneID; 8576; -.
DR   KEGG; hsa:8576; -.
DR   MANE-Select; ENST00000396738.7; ENSP00000379964.2; NM_001330213.2; NP_001317142.1.
DR   UCSC; uc002vko.3; human.
DR   CTD; 8576; -.
DR   DisGeNET; 8576; -.
DR   GeneCards; STK16; -.
DR   HGNC; HGNC:11394; STK16.
DR   HPA; ENSG00000115661; Low tissue specificity.
DR   MIM; 604719; gene.
DR   neXtProt; NX_O75716; -.
DR   OpenTargets; ENSG00000115661; -.
DR   PharmGKB; PA36202; -.
DR   VEuPathDB; HostDB:ENSG00000115661; -.
DR   eggNOG; KOG2345; Eukaryota.
DR   GeneTree; ENSGT00550000075037; -.
DR   InParanoid; O75716; -.
DR   OMA; MHQYKVK; -.
DR   OrthoDB; 831026at2759; -.
DR   PhylomeDB; O75716; -.
DR   TreeFam; TF350433; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; O75716; -.
DR   SignaLink; O75716; -.
DR   SIGNOR; O75716; -.
DR   BioGRID-ORCS; 8576; 12 hits in 1112 CRISPR screens.
DR   ChiTaRS; STK16; human.
DR   EvolutionaryTrace; O75716; -.
DR   GeneWiki; STK16; -.
DR   GenomeRNAi; 8576; -.
DR   Pharos; O75716; Tchem.
DR   PRO; PR:O75716; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O75716; protein.
DR   Bgee; ENSG00000115661; Expressed in mucosa of transverse colon and 115 other tissues.
DR   ExpressionAtlas; O75716; baseline and differential.
DR   Genevisible; O75716; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Kinase; Lipoprotein; Membrane;
KW   Myristate; Nucleotide-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..305
FT                   /note="Serine/threonine-protein kinase 16"
FT                   /id="PRO_0000086701"
FT   DOMAIN          20..293
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          166..202
FT                   /note="Activation loop"
FT   ACT_SITE        148
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         26..34
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         185
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:18184589"
FT   MOD_RES         197
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:18184589"
FT   MOD_RES         198
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:18184589"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:10364453"
FT   LIPID           6
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:10364453"
FT   LIPID           8
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:10364453"
FT   VARIANT         41
FT                   /note="H -> R (in dbSNP:rs34799131)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041140"
FT   VARIANT         55
FT                   /note="E -> K (in dbSNP:rs35947471)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041141"
FT   VARIANT         77
FT                   /note="I -> V (in dbSNP:rs34282267)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041142"
FT   VARIANT         266
FT                   /note="R -> W (in dbSNP:rs17849638)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|Ref.8"
FT                   /id="VAR_041143"
FT   VARIANT         277
FT                   /note="P -> L (in dbSNP:rs35454203)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041144"
FT   MUTAGEN         2
FT                   /note="G->A: Loss of myristoylation."
FT                   /evidence="ECO:0000269|PubMed:10364453"
FT   MUTAGEN         6
FT                   /note="C->S: Loss of palmitoylation."
FT                   /evidence="ECO:0000269|PubMed:10364453"
FT   MUTAGEN         8
FT                   /note="C->S: Loss of palmitoylation."
FT                   /evidence="ECO:0000269|PubMed:10364453"
FT   CONFLICT        59
FT                   /note="R -> L (in Ref. 6; AAV38392)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        180
FT                   /note="S -> P (in Ref. 7; BAF85383)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213
FT                   /note="D -> G (in Ref. 1; CAA06700 and 4; CAA09387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        221
FT                   /note="L -> F (in Ref. 2; AAC28337)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="G -> S (in Ref. 4; CAA09387)"
FT                   /evidence="ECO:0000305"
FT   STRAND          13..15
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          18..27
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          32..39
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   TURN            40..42
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          45..55
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           56..70
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          82..88
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          91..99
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   TURN            115..117
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           122..141
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           180..193
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           196..198
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   STRAND          208..212
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           215..230
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           236..240
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           245..250
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           263..272
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           277..279
FT                   /evidence="ECO:0007829|PDB:2BUJ"
FT   HELIX           283..292
FT                   /evidence="ECO:0007829|PDB:2BUJ"
SQ   SEQUENCE   305 AA;  34656 MW;  593B2AEB8505009C CRC64;
     MGHALCVCSR GTVIIDNKRY LFIQKLGEGG FSYVDLVEGL HDGHFYALKR ILCHEQQDRE
     EAQREADMHR LFNHPNILRL VAYCLRERGA KHEAWLLLPF FKRGTLWNEI ERLKDKGNFL
     TEDQILWLLL GICRGLEAIH AKGYAHRDLK PTNILLGDEG QPVLMDLGSM NQACIHVEGS
     RQALTLQDWA AQRCTISYRA PELFSVQSHC VIDERTDVWS LGCVLYAMMF GEGPYDMVFQ
     KGDSVALAVQ NQLSIPQSPR HSSALRQLLN SMMTVDPHQR PHIPLLLSQL EALQPPAPGQ
     HTTQI
//
